Karan Dewnani

Karan Dewnani has a diverse work experience in the pharmaceutical industry. They began their career as a Research Assistant at Anaheim Clinical Trials in June 2014. In December 2014, they transitioned to the role of Clinical Project Assistant I at US Biotest, Inc. and held this position until May 2017. They then advanced to the role of Clinical Project Assistant II for a brief period from June to August 2017.

In August 2017, Karan joined NanOlogy as a Manager of Corporate Development. They concurrently took on the role of Pharmaceutical Market Analyst at US Biotest, Inc. During their time with NanOlogy, their responsibilities primarily focused on corporate development.

Finally, in July 2021, Karan became a Corporate Development Analyst at DFB Pharmaceuticals LLC, where they supported the company's corporate development initiatives. In October 2022, they were promoted to the position of Manager of Corporate Development, a role that they currently hold.

Karan Dewnani attended the Charter School of Wilmington from 2009 to 2013, where they earned their High School diploma. Following this, they pursued a Bachelor's Degree in Biomedical/Medical Engineering at California Polytechnic State University-San Luis Obispo from 2013 to 2017. In addition to their formal education, Karan has also obtained the CFA Level 1 certification from the CFA Institute, however, the exact month and year of obtaining this certification are not specified.